4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-19-000011
Options or other derivatives
- Chief Scientific Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kishimoto Takashi Kei · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2019-01-07 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +100,000 | $2.60 | $260,000 | $2.60 | 2029-01-06 | 100,000 | 100,000 | D |
Loading xslF345X03/wf-form4_154698234281465.xml…